PATIENT-REPORTED OUTCOME DATA FROM THE LUX-LUNG 8 PHASE III GLOBAL TRIAL OF AFATINIB VERSUS ERLOTINIB AS SECOND-LINE TREATMENT FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE LUNG FOLLOWING FIRST-LINE PLATINUM-BASED CHEMOTHERAPY.
ONCOLOGY NURSING FORUM, cilt.43, sa.2, 2016 (SCI-Expanded, SSCI, Scopus)
- Yayın Türü: Makale / Özet
- Cilt numarası: 43 Sayı: 2
- Basım Tarihi: 2016
- Dergi Adı: ONCOLOGY NURSING FORUM
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
- Akdeniz Üniversitesi Adresli: Evet